SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Genzyme Tissue Repair - GZTR -- Ignore unavailable to you. Want to Upgrade?


To: Dave Feldman who wrote (389)5/18/2000 4:48:00 PM
From: KLH  Read Replies (1) | Respond to of 405
 
I voted for the changes.....however, I
hope the merger vote gets a thumbs down.
There is no way that BXM should get the
cash per share as originally proposed,
given the 50% decline in its stock price.
Aso, there are rumblings of a negative nature
about the quality of BXM's key products.
As for GZTR's recent stock price....it sucks!

Karl